“DI vs CSW - The Ultimate Clinical Dilemma"

Clinical Vignette

A 45-year-old male is admitted to the ICU following a severe traumatic brain injury (TBI) with subarachnoid hemorrhage. To manage cerebral edema, he is receiving intermittent doses of mannitol and a continuous 3% hypertonic saline infusion. By day 3 post-injury, he develops polyuria and a rising serum sodium level that has now reached 164 mmol/L. Despite aggressive fluid replacement, his serum sodium continues to climb, and he develops hypotension, necessitating further fluid resuscitation. Laboratory results reveal a creatinine of 1.6 mg/dL (baseline 0.9 mg/dL), low urine sodium concentration, serum hypernatremia, and high plasma osmolality.

The ICU team is now facing a diagnostic and therapeutic dilemma: Is this Diabetes Insipidus (DI), Cerebral Salt Wasting (CSW), or a combination influenced by hyperosmolar therapies and mild renal impairment?

Key Questions at the Bedside

"*" indicates required fields

1. Which of the following features differentiate diabetes insipidus from cerebral salt wasting (in the absence of osmotherapy)?
2. Which of the following features differentiate SIADH from cerebral salt wasting?
3. What factors would guide the decision to modify or discontinue mannitol?
4. All the following are risk factors for developing osmotic demyelination syndrome except
5. For a patient with Traumatic brain injury on osmotherapy, which of the following statements are false
6. What are the benefits of considering CRRT in cases of osmotherapy induced refractory hypernatremia and TBI?
7. Which of the following drugs are described in the management of diabetes insipidus?
8. For patients with TBI, on hypertonic saline osmotherapy, which of the following is not a feature of cerebral salt wasting?
Name*
This field is for validation purposes and should be left unchanged.

Loading

Leave Your Comment

BLOG EXPLAINATION WILL BE LIVE AFTER